Celebi, A. 2012. The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H-pylori eradication therapy. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.6 , 805-806.

Celebi, A., (2012). The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H-pylori eradication therapy. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.6, 805-806.

Celebi, ALTAY. "The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H-pylori eradication therapy," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.6, 805-806, 2012

Celebi, ALTAY. "The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H-pylori eradication therapy." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.6, pp.805-806, 2012

Celebi, A. (2012) . "The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H-pylori eradication therapy." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.23, no.6, pp.805-806.

@article{article, author={ALTAY ÇELEBİ}, title={The prevalence of CYP2C19 mutations in Turkish patients with dyspepsia and influence on H-pylori eradication therapy}, journal={TURKISH JOURNAL OF GASTROENTEROLOGY}, year=2012, pages={805-806} }